Controversies in neonatal sepsis: immunomodulation in the treatment and prevention of neonatal sepsis.
Moss
Samantha J
SJ
Neonatal Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Gennery
Andrew R
AR
D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007231:Infant, Newborn; D018805:Sepsis / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy*
D006133:Growth Substances; D007155:Immunologic Factors